A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
All genders
Phase 2
Interventional
This phase II trial studies how well combination chemotherapy works in treating patients withwly diagnosed stage II-IV diffuse anaplastic Wilms tumors (DAWT) or favorable histology Wilms tumors (FHWT) that have come back (relapsed). Drugs used in chemotherapy regimens suchH-3 (vincristine, doxorubicin, cyclophosphamide, carboplatin, etoposide, and irinotecan)d ICE/Cyclo/Topo (ifosfamide, carboplatin, etoposide, …